Urogesic Blue Tablet, Coated
NDC Package 0485-0151-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Urogesic Blue (methenamine, sodium phosphate, monobasic, methylene blue, and hyoscyamine sulfate) tablets is uROGESIC-BLUE™ is indicated for the treatment of symptoms of irritative voiding. This formulation utilizes a tablet, coated delivery system. Marketed by Edwards Pharmaceuticals, Inc., this product is identified by NDC 0485-0151.

Identification & Billing

NDC Package Code
0485-0151-01
Package Description
100 TABLET, COATED in 1 BOTTLE, PLASTIC
Product Code
0485-0151
11-Digit Billing Format
00485015101
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 1050325 - methenamine 81.6 MG / sodium phosphate, monobasic 40.8 MG / methylene blue 10.8 MG / hyoscyamine sulfate 0.12 MG Oral Tablet
  • RxCUI: 1050325 - hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet
  • RxCUI: 1251290 - UROGESIC-BLUE 81.6 MG / 40.8 MG / 10.8 MG / 0.12 MG Oral Tablet, Reformulated Apr 2012
  • RxCUI: 1251290 - hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urogesic Blue Reformulated Apr 2012]
  • RxCUI: 1251290 - Urogesic Blue (hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet, Reformulated Apr 2012

Clinical Specifications

Proprietary Name
Urogesic Blue
Non-Proprietary Name
Methenamine, Sodium Phosphate, Monobasic, Methylene Blue, And Hyoscyamine Sulfate
Substance Name
Hyoscyamine Sulfate; Methenamine; Methylene Blue; Sodium Phosphate, Monobasic
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
  • Oral - Administration to or by way of the mouth.
  • Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
UROGESIC-BLUE™ is indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as hypermotility which accompany lower urinary tract infections and as antispasmodic. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.

Regulatory & Marketing

Labeler Name
Edwards Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
11-19-2010
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0485-0151). Click a package code to view its specific billing and regulatory data.

0485-0151-30
30 TABLET, COATED in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0485-0151-01 identifies a specific commercial package of 100 tablet, coated in 1 bottle, plastic of Urogesic Blue, a human prescription drug labeled by Edwards Pharmaceuticals, Inc.. This tablet, coated is formulated for oral use and contains hyoscyamine sulfate; methenamine; methylene blue; sodium phosphate, monobasic as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Edwards Pharmaceuticals, Inc. on November 19, 2010. The current certification is valid through December 31, 2026.

How is this Edwards Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00485015101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0485-0151-01
11-Digit CMS (5-4-2)
00485-0151-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.